The DOI matches its Crossref record; 254 of the 254 references it cites were found in a registry or an index.
Environmental pollutants as risk factors for neurodegenerative disorders: Alzheimer and Parkinson diseases
Open accessAbstract
Neurodegenerative diseases including Alzheimer (AD) and Parkinson (PD) have attracted attention in last decades due to their high incidence worldwide. The etiology of these diseases is still unclear; however the role of the environment as a putative risk factor has gained importance. More worryingly is the evidence that pre- and post-natal exposures to environmental factors predispose to the onset of neurodegenerative diseases in later life. Neurotoxic metals such as lead, mercury, aluminum, cadmium and arsenic, as well as some pesticides and metal-based nanoparticles have been involved in AD due to their ability to increase beta-amyloid (Aβ) peptide and the phosphorylation of Tau protein (P-Tau), causing senile/amyloid plaques and neurofibrillary tangles (NFTs) characteristic of AD. The exposure to lead, manganese, solvents and some pesticides has been related to hallmarks of PD such as mitochondrial dysfunction, alterations in metal homeostasis and aggregation of proteins such as α-synuclein (α-syn), which is a key constituent of Lewy bodies (LB), a crucial factor in PD pathogenesis. Common mechanisms of environmental pollutants to increase Aβ, P-Tau, α-syn and neuronal death have been reported, including the oxidative stress mainly involved in the increase of Aβ and α-syn, and the reduced activity/protein levels of Aβ degrading enzyme (IDE)s such as neprilysin or insulin IDE. In addition, epigenetic mechanisms by maternal nutrient supplementation and exposure to heavy metals and pesticides have been proposed to lead phenotypic diversity and susceptibility to neurodegenerative diseases. This review discusses data from epidemiological and experimental studies about the role of environmental factors in the development of idiopathic AD and PD, and their mechanisms of action.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Alzheimer's disease: the amyloid cascade hypothesis
Hardy, J. A., & Higgins, G. A. (1992) · Science · doi:10.1126/science.1566067 · Cited by 7,484 · cited 1×
“The amyloid cascade hypothesis establishes that Aβ aggregation initiates the brain damage leading to memory loss and to AD (Hardy and Higgins, 1992).”
BackgroundDNA methylation patterns and epigenetic memory
Bird, A. (2002) · Genes & Development · doi:10.1101/gad.947102 · Cited by 7,124
Parkinson's disease: clinical features and diagnosis
Jankovic, J. (2008) · Journal of Neurology, Neurosurgery & Psychiatry · doi:10.1136/jnnp.2007.131045 · Cited by 5,720 · cited 3×
“The motor symptoms appear when at least 60% of dopaminergic neurons are lost and 80–85% of dopamine content in the striatum is depleted (Jankovic, 2008; Wirdefeldt et al., 2011).”
Chronic Parkinsonism in Humans Due to a Product of Meperidine-Analog Synthesis
Langston, J. W., Ballard, P., Tetrud, J. W., & Irwin, I. (1983) · Science · doi:10.1126/science.6823561 · Cited by 4,914
Oxidative mechanisms in the toxicity of metal ions
Stohs, S. J., & Bagchi, D. (1995) · Free Radical Biology and Medicine · doi:10.1016/0891-5849(94)00159-h · Cited by 4,219 · cited 2×
“Tokimasa, M., Minoura, K., Hiraoka, S., Tomoo, K., Sumida, M., Taniguchi, T., et al. (2005). Importance of local structures of second and third repeat fragments of microtubule-binding domain for tau filament formation.”
BackgroundGauthier, S., Reisberg, B., Zaudig, M., Petersen, R. C., Ritchie, K., Broich, K., Belleville, S., Brodaty, H., Bennett, D., Chertkow, H., et al. (2006) · The Lancet · doi:10.1016/s0140-6736(06)68542-5 · Cited by 3,850
Nanomaterials and nanoparticles: Sources and toxicity
Buzea, C., Pacheco, I. I., & Robbie, K. (2007) · Biointerphases · doi:10.1116/1.2815690 · Cited by 3,789
Chronic systemic pesticide exposure reproduces features of Parkinson's disease
Betarbet, R., Sherer, T. B., MacKenzie, G., Garcia-Osuna, M., Panov, A. V., & Greenamyre, J. T. (2000) · Nature Neuroscience · doi:10.1038/81834 · Cited by 3,683
Frequency Dependence of Signal Power and Spatial Reach of the Local Field Potential
Leski, S., Lindén, H., Tetzlaff, T., Pettersen, K. H., & Einevoll, G. T. (2013) · PubMed · doi:10.18154/rwth-conv-084442 · Cited by 3,639
The relevance of the Lewy body to the pathogenesis of idiopathic Parkinson's disease.
Gibb, W. R., & Lees, A. J. (1988) · Journal of Neurology, Neurosurgery & Psychiatry · doi:10.1136/jnnp.51.6.745 · Cited by 3,481
Spillantini, M. G., Crowther, R. A., Jakes, R., Hasegawa, M., & Goedert, M. (1998) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.95.11.6469 · Cited by 2,868
Free radicals, antioxidants, and human disease: where are we now?
Halliwell, B. B., Gutteridge, J. M. C., & Cross, C. E. (1992) · PubMed · Cited by 2,610
A Century of Alzheimer's Disease
Goedert, M., & Spillantini, M. G. (2006) · Science · doi:10.1126/science.1132814 · Cited by 2,098
Iron, brain ageing and neurodegenerative disorders
Zecca, L., Youdim, M. B. H., Riederer, P., Connor, J. R., & Crichton, R. R. (2004) · Nature Reviews Neuroscience · doi:10.1038/nrn1537 · Cited by 1,801
Rotenone, Paraquat, and Parkinson’s Disease
Tanner, C. M., Kamel, F., Ross, G. W., Hoppin, J. A., Goldman, S. M., Korell, M., Marras, C., Bhudhikanok, G. S., Kasten, M., Chade, A. R., et al. (2011) · Environmental Health Perspectives · doi:10.1289/ehp.1002839 · Cited by 1,475
A subset of NSAIDs lower amyloidogenic Aβ42 independently of cyclooxygenase activity
Weggen, S., Eriksen, J. L., Das, P., Sagi, S. A., Wang, R., Pietrzik, C. U., Findlay, K. A., Smith, T. E., Murphy, M. P., Bulter, T., et al. (2001) · Nature · doi:10.1038/35102591 · Cited by 1,388 · cited 2×
“The role of inflammatory processes in AD is supported by the use of non-steroidal anti-inflammatory drugs (NSAIDs) to reduce the Aβ levels (Weggen et al., 2001), and the risk of AD (Etminan et al., 2003).”
BackgroundIron accumulation in Alzheimer disease is a source of redox-generated free radicals
Smith, M. A., Harris, P. L. R., Sayre, L. M., & Perry, G. (1997) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.94.18.9866 · Cited by 1,355
Widespread Peroxynitrite-Mediated Damage in Alzheimer’s Disease
Smith, M. A., Richey Harris, P. L., Sayre, L. M., Beckman, J. S., & Perry, G. (1997) · The Journal of Neuroscience · doi:10.1523/jneurosci.17-08-02653.1997 · Cited by 1,239
Epidemiology and etiology of Parkinson's disease: a review of the evidence
Wirdefeldt, K., Adami, H.-O., Cole, P., Trichopoulos, D., & Mandel, J. (2011) · European Journal of Epidemiology · doi:10.1007/s10654-011-9581-6 · Cited by 1,199
Amyloid Precursor Protein Trafficking, Processing, and Function
Thinakaran, G., & Koo, E. H. (2008) · Journal of Biological Chemistry · doi:10.1074/jbc.r800019200 · Cited by 1,141
Goedert, M., Wischik, C. M., Crowther, R. A., Walker, J. E., & Klug, A. (1988) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.85.11.4051 · Cited by 1,134 · cited 1×
“Tau is a phosphoprotein mainly localized in the axon of neurons for the stabilization of MTs; it contains a high number of serine and threonine residues, and is therefore a substrate of many kinases (Goedert et al., 1988).”
BackgroundEvidence of oxidative damage in Alzheimer's disease brain: central role for amyloid β-peptide
Butterfield, D. A., Drake, J., Pocernich, C., & Castegna, A. (2001) · Trends in Molecular Medicine · doi:10.1016/s1471-4914(01)02173-6 · Cited by 1,114
DEXTER, D. T., CARAYON, A., JAVOY-AGID, F., AGID, Y., WELLS, F. R., DANIEL, S. E., LEES, A. J., JENNER, P., & MARSDEN, C. D. (1991) · Brain · doi:10.1093/brain/114.4.1953 · Cited by 1,043 · cited 1×
“Alterations in iron distribution have been observed in the substantia nigra of PD postmortem brains (Dexter et al., 1987, 1991; Hirsch et al., 1991).”
BackgroundAtwood, C. S., Moir, R. D., Huang, X., Scarpa, R. C., Bacarra, N. M. E., Romano, D. M., Hartshorn, M. A., Tanzi, R. E., & Bush, A. I. (1998) · Journal of Biological Chemistry · doi:10.1074/jbc.273.21.12817 · Cited by 1,009 · cited 2×
“Negative effects of Hg on Aβ aggregation have also been published, for example, Atwood et al. (1998) studied the role of the pH and the ability of various metals to aggregate Aβ; Zn, Cu and Fe showed the highest potential on Aβ aggregation, and Hg did not show an important effect (Atwood et al.,…”
BackgroundIncreased nigral iron content in postmortem parkinsonian brain
Dexter, D. T., Wells, F. R., Agid, F., Agid, Y., Lees, A. J., Jenner, P., & Marsden, C. D. (1987) · The Lancet · doi:10.1016/s0140-6736(87)91361-4 · Cited by 963
William Langston, J., Forno, L. S., Rebert, C. S., & Irwin, I. (1984) · Brain Research · doi:10.1016/0006-8993(84)90777-7 · Cited by 922
Adult mouse astrocytes degrade amyloid-β in vitro and in situ
Wyss-Coray, T., Loike, J. D., Brionne, T. C., Lu, E., Anankov, R., Yan, F., Silverstein, S. C., & Husemann, J. (2003) · Nature Medicine · doi:10.1038/nm838 · Cited by 909
McCormack, A. L., Thiruchelvam, M., Manning-Bog, A. B., Thiffault, C., Langston, J. W., Cory-Slechta, D. A., & Di Monte, D. A. (2002) · Neurobiology of Disease · doi:10.1006/nbdi.2002.0507 · Cited by 838
A highly reproducible rotenone model of Parkinson's disease
Cannon, J. R., Tapias, V., Na, H. M., Honick, A. S., Drolet, R. E., & Greenamyre, J. T. (2009) · Neurobiology of Disease · doi:10.1016/j.nbd.2009.01.016 · Cited by 795
The role of inflammation in Alzheimer’s disease
Tuppo, E. E., & Arias, H. R. (2005) · The International Journal of Biochemistry & Cell Biology · doi:10.1016/j.biocel.2004.07.009 · Cited by 734
Epigenetics: A Historical Overview
Holliday, R. (2006) · Epigenetics · doi:10.4161/epi.1.2.2762 · Cited by 710
Sherer, T. B., Kim, J.-H., Betarbet, R., & Greenamyre, J. T. (2003) · Experimental Neurology · doi:10.1006/exnr.2002.8072 · Cited by 708
The Herbicide Paraquat Causes Up-regulation and Aggregation of α-Synuclein in Mice
Manning-Bog, A. B., McCormack, A. L., Li, J., Uversky, V. N., Fink, A. L., & Di Monte, D. A. (2002) · Journal of Biological Chemistry · doi:10.1074/jbc.c100560200 · Cited by 684
Pb Neurotoxicity: Neuropsychological Effects of Lead Toxicity
Mason, L. H., Harp, J. P., & Han, D. Y. (2014) · BioMed Research International · doi:10.1155/2014/840547 · Cited by 668
Proteasomal function is impaired in substantia nigra in Parkinson’s disease
McNaught, K. S. P., & Jenner, P. (2001) · Neuroscience Letters · doi:10.1016/s0304-3940(00)01701-8 · Cited by 653
Epidemiology of parkinson’s disease
Tanner, C. M., & Goldman, S. M. (1996) · Neurologic Clinics · doi:10.1016/s0733-8619(05)70259-0 · Cited by 640 · cited 2×
“In addition to the aging, which is the main risk factor for PD (Tanner and Goldman, 1996), epidemiological evidence suggests that the exposure to environmental toxicants, mainly pesticides, metals and solvents could increase the risk of developing PD, and factors such as tobacco consumption can…”
BackgroundEnvironmental risk factors and Parkinson's disease: A case‐control study in Taiwan
Liou, H. H., Tsai, M. C., Chen, C. J., Jeng, J. S., Chang, Y. C., Chen, S. Y., & Chen, R. C. (1997) · Neurology · doi:10.1212/wnl.48.6.1583 · Cited by 616
What Genetics Tells us About the Causes and Mechanisms of Parkinson's Disease
Corti, O., Lesage, S., & Brice, A. (2011) · Physiological Reviews · doi:10.1152/physrev.00022.2010 · Cited by 611
Nanotoxicity of iron oxide nanoparticle internalization in growing neurons
Pisanic, T. R., Blackwell, J. D., Shubayev, V. I., Fiñones, R. R., & Jin, S. (2007) · Biomaterials · doi:10.1016/j.biomaterials.2007.01.043 · Cited by 585
Cadmium and Its Neurotoxic Effects
Wang, B., & Du, Y. (2013) · Oxidative Medicine and Cellular Longevity · doi:10.1155/2013/898034 · Cited by 584
Sherer, T. B., Betarbet, R., Stout, A. K., Lund, S., Baptista, M., Panov, A. V., Cookson, M. R., & Greenamyre, J. T. (2002) · The Journal of Neuroscience · doi:10.1523/jneurosci.22-16-07006.2002 · Cited by 581
Mogi, M., Harada, M., Narabayashi, H., Inagaki, H., Minami, M., & Nagatsu, T. (1996) · Neuroscience Letters · doi:10.1016/0304-3940(96)12706-3 · Cited by 545
Tyler, C. R., & Allan, A. M. (2014) · Current Environmental Health Reports · doi:10.1007/s40572-014-0012-1 · Cited by 537
Hirsch, E. C., Brandel, J. ‐., Galle, P., Javoy‐Agid, F., & Agid, Y. (1991) · Journal of Neurochemistry · doi:10.1111/j.1471-4159.1991.tb08170.x · Cited by 537
Etminan, M., Gill, S., & Samii, A. (2003) · BMJ · doi:10.1136/bmj.327.7407.128 · Cited by 511
Environmental Toxins and Parkinson's Disease
Goldman, S. M. (2014) · Annual Review of Pharmacology and Toxicology · doi:10.1146/annurev-pharmtox-011613-135937 · Cited by 505
Miñones-Moyano, E., Porta, S., Escaramís, G., Rabionet, R., Iraola, S., Kagerbauer, B., Espinosa-Parrilla, Y., Ferrer, I., Estivill, X., & Martí, E. (2011) · Human Molecular Genetics · doi:10.1093/hmg/ddr210 · Cited by 482
Mitochondria Are a Major Source of Paraquat-induced Reactive Oxygen Species Production in the Brain
Castello, P. R., Drechsel, D. A., & Patel, M. (2007) · Journal of Biological Chemistry · doi:10.1074/jbc.m700827200 · Cited by 477
Wu, J., Basha, M. R., Brock, B., Cox, D. P., Cardozo-Pelaez, F., McPherson, C. A., Harry, J., Rice, D. C., Maloney, B., Chen, D., et al. (2008) · The Journal of Neuroscience · doi:10.1523/jneurosci.4405-07.2008 · Cited by 470
Environmental Risk Factors and Parkinson's Disease: A Metaanalysis
Priyadarshi, A., Khuder, S. A., Schaub, E. A., & Priyadarshi, S. S. (2001) · Environmental Research · doi:10.1006/enrs.2001.4264 · Cited by 446
Pesticide exposure and risk for Parkinson's disease
Ascherio, A., Chen, H., Weisskopf, M. G., O'Reilly, E., McCullough, M. L., Calle, E. E., Schwarzschild, M. A., & Thun, M. J. (2006) · Annals of Neurology · doi:10.1002/ana.20904 · Cited by 445
Distinct Role for Microglia in Rotenone-Induced Degeneration of Dopaminergic Neurons
Gao, H.-M., Hong, J.-S., Zhang, W., & Liu, B. (2002) · The Journal of Neuroscience · doi:10.1523/jneurosci.22-03-00782.2002 · Cited by 439
Jowaed, A., Schmitt, I., Kaut, O., & Wüllner, U. (2010) · The Journal of Neuroscience · doi:10.1523/jneurosci.6119-09.2010 · Cited by 434
Pesticides and Parkinson’s Disease—Is There a Link?
Brown, T. P., Rumsby, P. C., Capleton, A. C., Rushton, L., & Levy, L. S. (2006) · Environmental Health Perspectives · doi:10.1289/ehp.8095 · Cited by 430
Paraquat elicited neurobehavioral syndrome caused by dopaminergic neuron loss
Brooks, A. I., Chadwick, C. A., Gelbard, H. A., Cory-Slechta, D. A., & Federoff, H. J. (1999) · Brain Research · doi:10.1016/s0006-8993(98)01192-5 · Cited by 424
Wille, H., Drewes, G., Biernat, J., Mandelkow, E. M., & Mandelkow, E. (1992) · The Journal of cell biology · doi:10.1083/jcb.118.3.573 · Cited by 421
Parkinson's Disease in a Chemist Working with 1-Methyl-4-Phenyl-L,2,5,6-Tetrahydropyridine
(1983) · New England Journal of Medicine · doi:10.1056/nejm198308043090511 · Cited by 406
Duan, W., Ladenheim, B., Cutler, R. G., Kruman, I. I., Cadet, J. L., & Mattson, M. P. (2002) · Journal of Neurochemistry · doi:10.1046/j.0022-3042.2001.00676.x · Cited by 405
Occupational exposure to pesticides increases the risk of incident AD: The Cache County Study
Hayden, K. M., Norton, M. C., Darcey, D., Østbye, T., Zandi, P. P., Breitner, J. C. S., & Welsh-Bohmer, K. A. (2010) · Neurology · doi:10.1212/wnl.0b013e3181dd4423 · Cited by 388
The relevance of iron in the pathogenesis of Parkinson’s disease
Sian‐Hülsmann, J., Mandel, S., Youdim, M. B. H., & Riederer, P. (2011) · Journal of Neurochemistry · doi:10.1111/j.1471-4159.2010.07132.x · Cited by 352
Parkinson's disease and brain levels of organochlorine pesticides
Fleming, L., Mann, J. B., Bean, J., Briggle, T., & Sanchez‐Ramos, J. R. (1994) · Annals of Neurology · doi:10.1002/ana.410360119 · Cited by 352
Uversky, V. N., Li, J., & Fink, A. L. (2001) · FEBS Letters · doi:10.1016/s0014-5793(01)02597-2 · Cited by 350
Parkinson’s disease risk from ambient exposure to pesticides
Wang, A., Costello, S., Cockburn, M., Zhang, X., Bronstein, J., & Ritz, B. (2011) · European Journal of Epidemiology · doi:10.1007/s10654-011-9574-5 · Cited by 349
Basha, M. R., Wei, W., Bakheet, S. A., Benitez, N., Siddiqi, H. K., Ge, Y.-W., Lahiri, D. K., & Zawia, N. H. (2005) · The Journal of Neuroscience · doi:10.1523/jneurosci.4335-04.2005 · Cited by 349
Manganese Poisoning in Moroccan Miners
Rodier, J. (1955) · Occupational and Environmental Medicine · doi:10.1136/oem.12.1.21 · Cited by 345
Betarbet, R., Canet-Aviles, R. M., Sherer, T. B., Mastroberardino, P. G., McLendon, C., Kim, J.-H., Lund, S., Na, H.-M., Taylor, G., Bence, N. F., et al. (2006) · Neurobiology of Disease · doi:10.1016/j.nbd.2005.12.003 · Cited by 342
Sherer, T. B., Richardson, J. R., Testa, C. M., Seo, B. B., Panov, A. V., Yagi, T., Matsuno‐Yagi, A., Miller, G. W., & Greenamyre, J. T. (2007) · Journal of Neurochemistry · doi:10.1111/j.1471-4159.2006.04333.x · Cited by 341
Pesticide Exposure and Self-reported Parkinson's Disease in the Agricultural Health Study
Kamel, F., Tanner, C., Umbach, D., Hoppin, J., Alavanja, M., Blair, A., Comyns, K., Goldman, S., Korell, M., Langston, J., et al. (2006) · American Journal of Epidemiology · doi:10.1093/aje/kwk024 · Cited by 339
Epigenetics, oxidative stress, and Alzheimer disease
Zawia, N. H., Lahiri, D. K., & Cardozo-Pelaez, F. (2009) · Free Radical Biology and Medicine · doi:10.1016/j.freeradbiomed.2009.02.006 · Cited by 337
The Neuropathology of Manganese-Induced Parkinsonism
Perl, D. P., & Olanow, C. W. (2007) · Journal of Neuropathology & Experimental Neurology · doi:10.1097/nen.0b013e31812503cf · Cited by 324
Neurodegenerative Diseases and Exposure to Pesticides in the Elderly
Baldi, I. (2003) · American Journal of Epidemiology · doi:10.1093/aje/kwf216 · Cited by 321
A meta-analysis of Parkinson's disease and exposure to pesticides.
Priyadarshi, A., Khuder, S., Schaub, E. A., & Shrivastava, S. (2000) · PubMed · Cited by 319
Parkinson's disease and pesticides: a toxicological perspective
HATCHER, J., PENNELL, K., & MILLER, G. (2008) · Trends in Pharmacological Sciences · doi:10.1016/j.tips.2008.03.007 · Cited by 319
Paraquat and Parkinson's disease
Berry, C., La Vecchia, C., & Nicotera, P. (2010) · Cell Death & Differentiation · doi:10.1038/cdd.2009.217 · Cited by 309
Matsumoto, L., Takuma, H., Tamaoka, A., Kurisaki, H., Date, H., Tsuji, S., & Iwata, A. (2010) · PLoS ONE · doi:10.1371/journal.pone.0015522 · Cited by 308
α-Synuclein Sequesters Dnmt1 from the Nucleus
Desplats, P., Spencer, B., Coffee, E., Patel, P., Michael, S., Patrick, C., Adame, A., Rockenstein, E., & Masliah, E. (2011) · Journal of Biological Chemistry · doi:10.1074/jbc.c110.212589 · Cited by 305
Zheng, W., & Monnot, A. D. (2012) · Pharmacology & Therapeutics · doi:10.1016/j.pharmthera.2011.10.006 · Cited by 302
How valid is the clinical diagnosis of Parkinson's disease in the community?
Schrag, A. (2002) · Journal of Neurology, Neurosurgery & Psychiatry · doi:10.1136/jnnp.73.5.529 · Cited by 300
Free radical adducts induce alterations in DNAcytosine methylation.
Weitzman, S. A., Turk, P. W., Milkowski, D. H., & Kozlowski, K. (1994) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.91.4.1261 · Cited by 299
Rogers, J. T., Leiter, L. M., McPhee, J., Cahill, C. M., Zhan, S.-S., Potter, H., & Nilsson, L. N. G. (1999) · Journal of Biological Chemistry · doi:10.1074/jbc.274.10.6421 · Cited by 290 · cited 5×
“Authors also observed (Ashok et al., 2015) increased levels of malondialdehyde (MDA), reduced activity of antioxidant enzymes, and the induction of 1L-1α and IL-1β in the frontal cortex and hippocampus of rats exposed to As + Pb + Cd mixture.”
BackgroundInfluentialParkinson's disease: A case‐control study of occupational and environmental risk factors
Hertzman, C., Wiens, M., Bowering, D., Snow, B., & Calne, D. (1990) · American Journal of Industrial Medicine · doi:10.1002/ajim.4700170307 · Cited by 290
Neurotoxicity of Silica Nanoparticles: Brain Localization and Dopaminergic Neurons Damage Pathways
Wu, J., Wang, C., Sun, J., & Xue, Y. (2011) · ACS Nano · doi:10.1021/nn103530b · Cited by 286
Aluminum modulates brain amyloidosis through oxidative stress in APP transgenic mice
Praticò, D., Uryu, K., Sung, S., Tang, S., Trojanowski, J. Q., & Lee, V. M. ‐. (2002) · The FASEB Journal · doi:10.1096/fj.02-0012fje · Cited by 278
Role of oxidative stress in paraquat‐induced dopaminergic cell degeneration
McCormack, A. L., Atienza, J. G., Johnston, L. C., Andersen, J. K., Vu, S., & Di Monte, D. A. (2005) · Journal of Neurochemistry · doi:10.1111/j.1471-4159.2005.03088.x · Cited by 278
Elevated Serum Pesticide Levels and Risk for Alzheimer Disease
Richardson, J. R., Roy, A., Shalat, S. L., von Stein, R. T., Hossain, M. M., Buckley, B., Gearing, M., Levey, A. I., & German, D. C. (2014) · JAMA Neurology · doi:10.1001/jamaneurol.2013.6030 · Cited by 263
Zlokovic, B. V., Deane, R., Sagare, A. P., Bell, R. D., & Winkler, E. A. (2010) · Journal of Neurochemistry · doi:10.1111/j.1471-4159.2010.07002.x · Cited by 261
Molecular mechanisms of pesticide-induced neurotoxicity: Relevance to Parkinson's disease
Franco, R., Li, S., Rodriguez-Rocha, H., Burns, M., & Panayiotidis, M. I. (2010) · Chemico-Biological Interactions · doi:10.1016/j.cbi.2010.06.003 · Cited by 257
Genetics of familial and sporadic Alzheimer s disease
Piaceri, I. (2013) · Frontiers in Bioscience · doi:10.2741/e605 · Cited by 256
Microglial activation as a priming event leading to paraquat-induced dopaminergic cell degeneration
Purisai, M. G., McCormack, A. L., Cumine, S., Li, J., Isla, M. Z., & Di Monte, D. A. (2007) · Neurobiology of Disease · doi:10.1016/j.nbd.2006.10.008 · Cited by 254
Pesticide exposure and Parkinson's disease: Epidemiological evidence of association
Freire, C., & Koifman, S. (2012) · NeuroToxicology · doi:10.1016/j.neuro.2012.05.011 · Cited by 253
ORGANOCHLORINE INSECTICIDES IN SUBSTANTIA NIGRA IN PARKINSON'S DISEASE
F.M. Corrigan, C. L. W. (2000) · Journal of Toxicology and Environmental Health, Part A · doi:10.1080/009841000156907 · Cited by 251
The involvement of microRNAs in neurodegenerative diseases
Maciotta, S., Meregalli, M., & Torrente, Y. (2013) · Frontiers in Cellular Neuroscience · doi:10.3389/fncel.2013.00265 · Cited by 245
Pesticide/Environmental Exposures and Parkinson's Disease in East Texas
Dhillon, A. S., Tarbutton, G. L., Levin, J. L., Plotkin, G. M., Lowry, L. K., Nalbone, J. T., & Shepherd, S. (2008) · Journal of Agromedicine · doi:10.1080/10599240801986215 · Cited by 238
Is Pesticide Use Related to Parkinson Disease? Some Clues to Heterogeneity in Study Results
van der Mark, M., Brouwer, M., Kromhout, H., Nijssen, P., Huss, A., & Vermeulen, R. (2012) · Environmental Health Perspectives · doi:10.1289/ehp.1103881 · Cited by 238
Rogers, J., & Lue, L.-F. (2001) · Neurochemistry International · doi:10.1016/s0197-0186(01)00040-7 · Cited by 236
McNaught, K. S. P., Belizaire, R., Jenner, P., Olanow, C. W., & Isacson, O. (2002) · Neuroscience Letters · doi:10.1016/s0304-3940(02)00296-3 · Cited by 232
Pesticides and Risk of Parkinson Disease: A Population-Based Case-Control Study
Firestone, J. A., Smith-Weller, T., Franklin, G., Swanson, P., Longstreth, W. T., & Checkoway, H. (2005) · Archives of Neurology · doi:10.1001/archneur.62.1.91 · Cited by 232
Multiple risk factors for Parkinson's disease
Gorell, J. M., Peterson, E. L., Rybicki, B. A., & Johnson, C. C. (2004) · Journal of the Neurological Sciences · doi:10.1016/j.jns.2003.09.014 · Cited by 230
Chronic Manganese Intoxication
Cook, D. G., Fahn, S., & Brait, K. A. (1974) · Archives of Neurology · doi:10.1001/archneur.1974.00490310061010 · Cited by 229
Metals and trace elements in plasma and cerebrospinal fluid in normal aging and Alzheimer's disease.
Basun, H., Forssell, L. G., Wetterberg, L., & Winblad, B. G. (1991) · PubMed · Cited by 228
Trichloroethylene: Parkinsonism and complex 1 mitochondrial neurotoxicity
Gash, D. M., Rutland, K., Hudson, N. L., Sullivan, P. G., Bing, G., Cass, W. A., Pandya, J. D., Liu, M., Choi, D., Hunter, R. L., et al. (2008) · Annals of Neurology · doi:10.1002/ana.21288 · Cited by 222
Radad, K., Rausch, W.-D., & Gille, G. (2006) · Neurochemistry International · doi:10.1016/j.neuint.2006.02.003 · Cited by 220
Blamey, F. P. C., Edwards, D. G., & Asher, C. J. (1983) · Soil Science · doi:10.1097/00010694-198310000-00001 · Cited by 220
Developmental Exposure to the Pesticides Paraquat and Maneb and the Parkinson’s Disease Phenotype
Thiruchelvam, M., Richfield, E. K., Goodman, B. M., Baggs, R. B., & Cory-Slechta, D. A. (2002) · NeuroToxicology · doi:10.1016/s0161-813x(02)00092-x · Cited by 214
The Non-Amyloidogenic Pathway: Structure and Function of α-Secretases
Kojro, E., & Fahrenholz, F. (2006) · Subcellular Biochemistry · doi:10.1007/0-387-23226-5_5 · Cited by 213
O’Bryant, S. E., Edwards, M., Menon, C. V., Gong, G., & Barber, R. (2011) · International Journal of Environmental Research and Public Health · doi:10.3390/ijerph8030861 · Cited by 211
Metal Concentrations in Plasma and Cerebrospinal Fluid in Patients with Alzheimer’s Disease
Gerhardsson, L., Lundh, T., Minthon, L., & Londos, E. (2008) · Dementia and Geriatric Cognitive Disorders · doi:10.1159/000129365 · Cited by 210
Olivieri, G., Brack, C., Müller‐Spahn, F., Stähelin, H. B., Herrmann, M., Renard, P., Brockhaus, M., & Hock, C. (2000) · Journal of Neurochemistry · doi:10.1046/j.1471-4159.2000.0740231.x · Cited by 209
Lipoperoxidative Damage on Lead Exposure in Rat Brain and its Implications on Membrane Bound Enzymes
Sandhir, R., Julka, D., & Dip Gill, K. (1994) · Pharmacology & Toxicology · doi:10.1111/j.1600-0773.1994.tb01077.x · Cited by 209
Paraquat neurotoxicity is mediated by the dopamine transporter and organic cation transporter-3
Rappold, P. M., Cui, M., Chesser, A. S., Tibbett, J., Grima, J. C., Duan, L., Sen, N., Javitch, J. A., & Tieu, K. (2011) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1115141108 · Cited by 209
Wang, C., Ko, H. S., Thomas, B., Tsang, F., Chew, K. C. M., Tay, S.-P., Ho, M. W. L., Lim, T.-M., Soong, T.-W., Pletnikova, O., et al. (2005) · Human Molecular Genetics · doi:10.1093/hmg/ddi413 · Cited by 207
Association of Cumulative Lead Exposure with Parkinson’s Disease
Weisskopf, M. G., Weuve, J., Nie, H., Saint-Hilaire, M.-H., Sudarsky, L., Simon, D. K., Hersh, B., Schwartz, J., Wright, R. O., & Hu, H. (2010) · Environmental Health Perspectives · doi:10.1289/ehp.1002339 · Cited by 206
Well-Water Consumption and Parkinson’s Disease in Rural California
Gatto, N. M., Cockburn, M., Bronstein, J., Manthripragada, A. D., & Ritz, B. (2009) · Environmental Health Perspectives · doi:10.1289/ehp.0900852 · Cited by 204
Dieldrin-Induced Neurotoxicity: Relevance to Parkinson's Disease Pathogenesis
Kanthasamy, A. G., Kitazawa, M., Kanthasamy, A., & Anantharam, V. (2005) · NeuroToxicology · doi:10.1016/j.neuro.2004.07.010 · Cited by 201
Progression after chronic manganese exposure
Huang, C.-C., Lu, C.-S., Chu, N.-S., Hochberg, F., Lilienfeld, D., Olanow, W., & Calne, D. B. (1993) · Neurology · doi:10.1212/wnl.43.8.1479 · Cited by 194
Trace element imbalances in isolated subcellular fractions of Alzheimer's disease brains
Wenstrup, D., Ehman, W. D., & Markesbery, W. R. (1990) · Brain Research · doi:10.1016/0006-8993(90)91804-p · Cited by 189
Guilarte, T. R. (2013) · Frontiers in Aging Neuroscience · doi:10.3389/fnagi.2013.00023 · Cited by 189
Sharma, H. S., Ali, S. F., Hussain, S. M., Schlager, J. J., & Sharma, A. (2009) · Journal of Nanoscience and Nanotechnology · doi:10.1166/jnn.2009.gr09 · Cited by 188
Occupational and environmental risk factors for Parkinson's disease
Lai, B. C. L., Marion, S. A., Teschke, K., & Tsui, J. K. C. (2002) · Parkinsonism & Related Disorders · doi:10.1016/s1353-8020(01)00054-2 · Cited by 188
Solvent exposures and parkinson disease risk in twins
Goldman, S. M., Quinlan, P. J., Ross, G. W., Marras, C., Meng, C., Bhudhikanok, G. S., Comyns, K., Korell, M., Chade, A. R., Kasten, M., et al. (2012) · Annals of Neurology · doi:10.1002/ana.22629 · Cited by 187
Neuronal dark matter: the emerging role of microRNAs in neurodegeneration
Goodall, E. F., Heath, P. R., Bandmann, O., Kirby, J., & Shaw, P. J. (2013) · Frontiers in Cellular Neuroscience · doi:10.3389/fncel.2013.00178 · Cited by 187
Kitazawa, M., Anantharam, V., & Kanthasamy, A. G. (2001) · Free Radical Biology and Medicine · doi:10.1016/s0891-5849(01)00726-2 · Cited by 186
Suri, S., Heise, V., Trachtenberg, A. J., & Mackay, C. E. (2013) · Neuroscience & Biobehavioral Reviews · doi:10.1016/j.neubiorev.2013.10.010 · Cited by 183 · cited 1×
“Therefore, ApoEε2 is considered a protective genotype for AD development (Suri et al., 2013).”
BackgroundProteasome inhibition in oxidative stress neurotoxicity: implications for heat shock proteins
Ding, Q., & Keller, J. N. (2001) · Journal of Neurochemistry · doi:10.1046/j.1471-4159.2001.00302.x · Cited by 181
Iwata, A., Nagata, K., Hatsuta, H., Takuma, H., Bundo, M., Iwamoto, K., Tamaoka, A., Murayama, S., Saido, T. C., & Tsuji, S. (2013) · Human Molecular Genetics · doi:10.1093/hmg/ddt451 · Cited by 180
The Role of Early Life Environmental Risk Factors in Parkinson Disease: What Is the Evidence?
Logroscino, G. (2005) · Environmental Health Perspectives · doi:10.1289/ehp.7573 · Cited by 179
Certain Metals Trigger Fibrillation of Methionine-oxidized α-Synuclein
Yamin, G., Glaser, C. B., Uversky, V. N., & Fink, A. L. (2003) · Journal of Biological Chemistry · doi:10.1074/jbc.m303302200 · Cited by 178
Ray, P. D., Yosim, A., & Fry, R. C. (2014) · Frontiers in Genetics · doi:10.3389/fgene.2014.00201 · Cited by 177
Ashok, A., Rai, N. K., Tripathi, S., & Bandyopadhyay, S. (2015) · Toxicological Sciences · doi:10.1093/toxsci/kfu208 · Cited by 177
Involvement of Environmental Mercury and Lead in the Etiology of Neurodegenerative Diseases
Monnet-Tschudi, F., Zurich, M.-G., Boschat, C., Corbaz, A., & Honegger, P. (2006) · Reviews on Environmental Health · doi:10.1515/reveh.2006.21.2.105 · Cited by 176
Antioxidant gene therapy against neuronal cell death
Navarro-Yepes, J., Zavala-Flores, L., Anandhan, A., Wang, F., Skotak, M., Chandra, N., Li, M., Pappa, A., Martinez-Fong, D., Del Razo, L. M., et al. (2014) · Pharmacology & Therapeutics · doi:10.1016/j.pharmthera.2013.12.007 · Cited by 176
Self-citationAlzheimer disease: mercury as pathogenetic factor and apolipoprotein E as a moderator.
Mutter, J., Naumann, J., Sadaghiani, C., Schneider, R., & Walach, H. (2004) · PubMed · Cited by 175
Vallelunga, A., Ragusa, M., Di Mauro, S., Iannitti, T., Pilleri, M., Biundo, R., Weis, L., Di Pietro, C., De Iuliis, A., Nicoletti, A., et al. (2014) · Frontiers in Cellular Neuroscience · doi:10.3389/fncel.2014.00156 · Cited by 175
Searching for a relationship between manganese and welding and Parkinson’s disease
Jankovic, J. (2005) · Neurology · doi:10.1212/01.wnl.0000166916.40902.63 · Cited by 175
Neuronal and microglial involvement in beta-amyloid protein deposition in Alzheimer's disease.
Cras, P. P., Kawai, M., Siedlak, S. L., Mulvihill, P., Gambetti, P. L., Lowery, D. E., Gonzalez‐DeWhitt, P. A., Greenberg, B., & Perry, G. L. (1990) · Europe PMC (PubMed Central) · Cited by 174
Kawahara, M., Kato, M., & Kuroda, Y. (2001) · Brain Research Bulletin · doi:10.1016/s0361-9230(01)00475-0 · Cited by 174
DNA methylation, a hand behind neurodegenerative diseases
Lu, H., Liu, X., Deng, Y., & Qing, H. (2013) · Frontiers in Aging Neuroscience · doi:10.3389/fnagi.2013.00085 · Cited by 174
Cookson, M. R. (2012) · Cold Spring Harbor Perspectives in Medicine · doi:10.1101/cshperspect.a009415 · Cited by 170
Wang, J. D., Huang, C. C., Hwang, Y. H., Chiang, J. R., Lin, J. M., & Chen, J. S. (1989) · Occupational and Environmental Medicine · doi:10.1136/oem.46.12.856 · Cited by 170
Are amyloid-degrading enzymes viable therapeutic targets in Alzheimer’s disease?
Nalivaeva, N. N., Beckett, C., Belyaev, N. D., & Turner, A. J. (2012) · Journal of Neurochemistry · doi:10.1111/j.1471-4159.2011.07510.x · Cited by 169
Diorthosubstituted Polychlorinated Biphenyls in Caudate Nucleus in Parkinson's Disease
Corrigan, F. M., Murray, L., Wyatt, C. L., & Shore, R. F. (1998) · Experimental Neurology · doi:10.1006/exnr.1998.6776 · Cited by 169
Gene–environment interactions: Key to unraveling the mystery of Parkinson's disease
Gao, H.-M., & Hong, J.-S. (2011) · Progress in Neurobiology · doi:10.1016/j.pneurobio.2011.03.005 · Cited by 165
Structure of tau protein and assembly into paired helical filaments
Friedhoff, P., von Bergen, M., Mandelkow, E.-M., & Mandelkow, E. (2000) · Biochimica et Biophysica Acta (BBA) - Molecular Basis of Disease · doi:10.1016/s0925-4439(00)00038-7 · Cited by 165
Neurobehavioural and molecular changes induced by methylmercury exposure during development
Johansson, C., Castoldi, A. F., Onishchenko, N., Manzo, L., Vahter, M., & Ceccatelli, S. (2007) · Neurotoxicity Research · doi:10.1007/bf03033570 · Cited by 164
Levels of alpha‐synuclein mRNA in sporadic Parkinson disease patients
Chiba‐Falek, O., Lopez, G. J., & Nussbaum, R. L. (2006) · Movement Disorders · doi:10.1002/mds.21007 · Cited by 164
Parkinson's disease mortality and the industrial use of heavy metals in Michigan
Rybicki, B. A., Johnson, C. C., Uman, J., & Gorell, J. M. (1993) · Movement Disorders · doi:10.1002/mds.870080116 · Cited by 163
Kitazawa, M., Anantharam, V., & Kanthasamy, A. G. (2003) · Neuroscience · doi:10.1016/s0306-4522(03)00226-4 · Cited by 163
Identification of blood serum micro‐RNAs associated with idiopathic and LRRK2 Parkinson's disease
Botta‐Orfila, T., Morató, X., Compta, Y., Lozano, J. J., Falgàs, N., Valldeoriola, F., Pont‐Sunyer, C., Vilas, D., Mengual, L., Fernández, M., et al. (2014) · Journal of Neuroscience Research · doi:10.1002/jnr.23377 · Cited by 162
Tau and transgenic animal models
Götz, J. (2001) · Brain Research Reviews · doi:10.1016/s0165-0173(01)00055-8 · Cited by 162
Persistent organochlorine pesticides in serum and risk of Parkinson disease
Weisskopf, M. G., Knekt, P., O'Reilly, E. J., Lyytinen, J., Reunanen, A., Laden, F., Altshul, L., & Ascherio, A. (2010) · Neurology · doi:10.1212/wnl.0b013e3181d76a93 · Cited by 162
Whole-Body Lifetime Occupational Lead Exposure and Risk of Parkinson’s Disease
Coon, S., Stark, A., Peterson, E., Gloi, A., Kortsha, G., Pounds, J., Chettle, D., & Gorell, J. (2006) · Environmental Health Perspectives · doi:10.1289/ehp.9102 · Cited by 161
Walton, J. R., & Wang, M.-X. (2009) · Journal of Inorganic Biochemistry · doi:10.1016/j.jinorgbio.2009.07.027 · Cited by 158
Huang, C.-L., Hsiao, I.-L., Lin, H.-C., Wang, C.-F., Huang, Y.-J., & Chuang, C.-Y. (2015) · Environmental Research · doi:10.1016/j.envres.2014.11.006 · Cited by 158
The Role of Microglia in Paraquat-Induced Dopaminergic Neurotoxicity
Wu, X.-F., Block, M. L., Zhang, W., Qin, L., Wilson, B., Zhang, W.-Q., Veronesi, B., & Hong, J.-S. (2005) · Antioxidants & Redox Signaling · doi:10.1089/ars.2005.7.654 · Cited by 158
Dieldrin exposure induces oxidative damage in the mouse nigrostriatal dopamine system
Hatcher-Martin, J. M., Richardson, J. R., Guillot, T. S., McCormack, A. L., Monte, D. A. D., Jones, D. P., Pennell, K. D., & Miller, G. W. (2007) · Experimental Neurology · doi:10.1016/j.expneurol.2006.12.020 · Cited by 156
Ze, Y., Hu, R., Wang, X., Sang, X., Ze, X., Li, B., Su, J., Wang, Y., Guan, N., Zhao, X., et al. (2013) · Journal of Biomedical Materials Research Part A · doi:10.1002/jbm.a.34705 · Cited by 154
Influence of Gold Nanoparticles on the Kinetics of α-Synuclein Aggregation
Álvarez, Y. D., Fauerbach, J. A., Pellegrotti, J. V., et al. (2013) · Nano Letters · doi:10.1021/nl403490e · Cited by 146
Increased murine neonatal iron intake results in Parkinson-like neurodegeneration with age
Kaur, D., Peng, J., Chinta, S. J., Rajagopalan, S., Monte, D. A. D., Cherny, R. A., & Andersen, J. K. (2006) · Neurobiology of Aging · doi:10.1016/j.neurobiolaging.2006.04.003 · Cited by 146
Baum, L., Chan, I. H. S., Cheung, S. K. K., Goggins, W. B., Mok, V., LAM, L. C. W., Leung, V., Hui, E., Ng, C., Woo, J., et al. (2009) · BioMetals · doi:10.1007/s10534-009-9277-5 · Cited by 141
Altmann, P., Cunningham, J., Dhanesha, U., Ballard, M., Thompson, J., & Marsh, F. (1999) · BMJ · doi:10.1136/bmj.319.7213.807 · Cited by 135
Epigenetically regulated microRNAs in Alzheimer's disease
van den Hove, D., Kompotis, K., Lardenoije, R., Kenis, G., Mill, J. S., Steinbusch, H. W. M., Lesch, K., Fitzsimons, C. P., Strooper, B. D., & Rutten, B. P. F. (2013) · Neurobiology of Aging · doi:10.1016/j.neurobiolaging.2013.10.082 · Cited by 134
Role of Epigenetics in Alzheimer ‘S and Parkinson‘S Disease
Kwok, J. B. (2010) · Epigenomics · doi:10.2217/epi.10.43 · Cited by 134
Acute and reversible parkinsonism due to organophosphate pesticide intoxication
Bhatt, M. H., Elias, M. A., & Mankodi, A. K. (1999) · Neurology · doi:10.1212/wnl.52.7.1467 · Cited by 131
Exley, C. (2006) · Journal of Neurology Neurosurgery & Psychiatry · doi:10.1136/jnnp.2005.086553 · Cited by 129
Aluminum modifies the properties of Alzheimer's disease PHF tau proteins in vivo and in vitro
Shin, R. W., Lee, V., & Trojanowski, J. Q. (1994) · Journal of Neuroscience · doi:10.1523/jneurosci.14-11-07221.1994 · Cited by 129
An interaction of β‐amyloid with aluminium in vitro
Exley, C., Price, N. C., Kelly, S. M., & Birchall, J. D. (1993) · FEBS Letters · doi:10.1016/0014-5793(93)80137-j · Cited by 128
The Arsenic Exposure Hypothesis for Alzheimer Disease
Gong, G., & O’Bryant, S. E. (2010) · Alzheimer Disease & Associated Disorders · doi:10.1097/wad.0b013e3181d71bc7 · Cited by 128
Cognitive impairment in rats induced by nano-CuO and its possible mechanisms
An, L., Liu, S., Yang, Z. R., & Zhang, T. (2012) · Toxicology Letters · doi:10.1016/j.toxlet.2012.07.007 · Cited by 128
Yang, X., He, C., Li, J., Chen, H., Ma, Q., Sui, X., Tian, S., Ying, M., Zhang, Q., Luo, Y., et al. (2014) · Toxicology Letters · doi:10.1016/j.toxlet.2014.05.009 · Cited by 127
Iron and reactive oxygen species activity in parkinsonian substantia nigra
del Nogal, A. W., Gałązka-Friedman, J., Bauminger, E. R., Wszołek, Z. K., Schweitzer, K. J., Dickson, D. W., Jaklewicz, A., Elbaum, D., & Friedman, A. (2010) · Parkinsonism & Related Disorders · doi:10.1016/j.parkreldis.2010.02.007 · Cited by 126
Paraquat Neurotoxicity Is Mediated by a Bak-dependent Mechanism
Fei, Q., McCormack, A. L., Monte, D. A. D., & Ethell, D. W. (2007) · Journal of Biological Chemistry · doi:10.1074/jbc.m708451200 · Cited by 124
Wills, J., Credle, J. J., Oaks, A. W., Duka, V., Lee, J., Jones, J. M., & Sidhu, A. (2012) · PLoS ONE · doi:10.1371/journal.pone.0030745 · Cited by 120
Zhao, Y., Bhattacharjee, S., Jones, B. M., Hill, J. M., Dua, P., & Lukiw, W. J. (2013) · Molecular Neurobiology · doi:10.1007/s12035-013-8595-3 · Cited by 119
Fujimura, M., Usuki, F., Sawada, M., & Takashima, A. (2009) · NeuroToxicology · doi:10.1016/j.neuro.2009.08.001 · Cited by 118
Trichloroethylene induces dopaminergic neurodegeneration in Fisher 344 rats
Liu, M., Choi, D., Hunter, R. L., Pandya, J. D., Cass, W. A., Sullivan, P. G., Kim, H., Gash, D. M., & Bing, G. (2009) · Journal of Neurochemistry · doi:10.1111/j.1471-4159.2009.06497.x · Cited by 118
Jiang, L., Yao, T., Zhu, Z.-L., Wang, C., & Ji, L. (2007) · Biochimica et Biophysica Acta (BBA) - Proteins and Proteomics · doi:10.1016/j.bbapap.2007.08.014 · Cited by 118
Pieper, H. C., Evert, B. O., Kaut, O., Riederer, P. F., Waha, A., & Wüllner, U. (2008) · Neurobiology of Disease · doi:10.1016/j.nbd.2008.09.010 · Cited by 117
Bihaqi, S. W., & Zawia, N. H. (2013) · NeuroToxicology · doi:10.1016/j.neuro.2013.07.010 · Cited by 114
Zhang, J., Cai, T., Zhao, F., Yao, T. S., Chen, Y., Liu, X., Luo, W., & Chen, J. (2012) · International Journal of Biological Sciences · doi:10.7150/ijbs.4499 · Cited by 112
Epigenetics in neurodegeneration: A new layer of complexity
Marques, S., Oliveira, C. R., Pereira, C., & Outeiro, T. F. (2010) · Progress in Neuro-Psychopharmacology and Biological Psychiatry · doi:10.1016/j.pnpbp.2010.08.008 · Cited by 109
The prospective role of abnormal methyl metabolism in cadmium toxicity.
Poirier, L. A., & Vlasova, T. I. (2002) · Environmental Health Perspectives · doi:10.1289/ehp.02110s5793 · Cited by 107
Increased blood mercury levels in patients with Alzheimer's disease
Hock, C., Drasch, G. A., Golombowski, S., Müller-Spahn, F., Willershausen-Zönnchen, B., Schwarz, P., Hock, U., Growdon, J. H., & Nitsch, R. M. (1998) · Journal of Neural Transmission · doi:10.1007/s007020050038 · Cited by 107
Dietary intake of metals and risk of Parkinson's disease: A case-control study in Japan
Miyake, Y., Tanaka, K., Fukushima, W., Sasaki, S., Kiyohara, C., Tsuboi, Y., Yamada, T., Oeda, T., Miki, T., Kawamura, N., et al. (2011) · Journal of the Neurological Sciences · doi:10.1016/j.jns.2011.03.035 · Cited by 106
Regulation of β‐site APP‐cleaving enzyme 1 gene expression and its role in Alzheimer’s Disease
Sun, X., Bromley‐Brits, K., & Song, W. (2011) · Journal of Neurochemistry · doi:10.1111/j.1471-4159.2011.07515.x · Cited by 105
Toxicity of Dieldrin for Dopaminergic Neurons in Mesencephalic Cultures
Sanchez‐Ramos, J., Facca, A., Basit, A., & Song, S. (1998) · Experimental Neurology · doi:10.1006/exnr.1997.6770 · Cited by 105
Ramos-Chávez, L. A., Rendón-López, C. R. R., Zepeda, A., Silva‐Adaya, D., Razo, L. M. D., & Gonsebatt, M. E. (2015) · Frontiers in Cellular Neuroscience · doi:10.3389/fncel.2015.00021 · Cited by 104
Aluminum and its potential contribution to Alzheimer's disease (AD)
Bhattacharjee, S., Zhao, Y., Hill, J. M., Percy, M. E., & Lukiw, W. J. (2014) · Frontiers in Aging Neuroscience · doi:10.3389/fnagi.2014.00062 · Cited by 104
Leyva-Gómez, G., Cortés, H., Magaña, J. J., Leyva-García, N., Quintanar-Guerrero, D., & Florán, B. (2015) · Drug Discovery Today · doi:10.1016/j.drudis.2015.02.009 · Cited by 102
Altered expression of Aβ metabolism-associated molecules from d-galactose/AlCl3 induced mouse brain
Luo, Y., Niu, F., Sun, Z.-Z., Cao, W., Zhang, X., Guan, D., Lv, Z., Zhang, B., & Xu, Y. (2008) · Mechanisms of Ageing and Development · doi:10.1016/j.mad.2008.12.005 · Cited by 102
Neurotoxicity of Engineered Nanoparticles from Metals
Sharma, H. S., & Sharma, A. (2012) · CNS & Neurological Disorders - Drug Targets · doi:10.2174/187152712799960817 · Cited by 101
Sun, F., Anantharam, V., Latchoumycandane, C., Kanthasamy, A., & Kanthasamy, A. G. (2005) · Journal of Pharmacology and Experimental Therapeutics · doi:10.1124/jpet.105.084632 · Cited by 99
Drechsel, D. A., & Patel, M. (2009) · Toxicological Sciences · doi:10.1093/toxsci/kfp223 · Cited by 99
Nutrition, Epigenetics, and Diseases
Jang, H., & Serra, C. (2014) · Clinical Nutrition Research · doi:10.7762/cnr.2014.3.1.1 · Cited by 99
The neuromelanin of human substantia nigra and its interaction with metals
Zecca, L., Tampellini, D., Gatti, A., Crippa, P. R., Eisner, M., Sulzer, D. L., Ito, S., Fariello, R. G., & Gallorini, M. (2002) · Journal of Neural Transmission · doi:10.1007/s007020200055 · Cited by 98
Smargiassi, A., Mutti, A., Rosa, A. D., Palma, G. D., Negrotti, A., & Calzetti, S. (1998) · PubMed · Cited by 95
Paraquat-induced apoptotic cell death in cerebellar granule cells
González‐Polo, R. A., Rodrı́guez-Martı́n, A., Morán, J. M., Niso‐Santano, M., Soler, G., & Fuentes, J. M. (2004) · Brain Research · doi:10.1016/j.brainres.2004.02.078 · Cited by 93
Wang, Y., Wang, X., Li, R., Yang, Z., Wang, Y., Gong, X., & Wang, X. (2013) · CNS Neuroscience & Therapeutics · doi:10.1111/cns.12059 · Cited by 93
Dietary Iron Intake and Risk of Parkinson's Disease
Logroscino, G., Gao, X., Chen, H., Wing, A., & Ascherio, A. (2008) · American Journal of Epidemiology · doi:10.1093/aje/kwn273 · Cited by 93
NF-κB-regulated, proinflammatory miRNAs in Alzheimer's disease
Lukiw, W. J. (2012) · Alzheimer s Research & Therapy · doi:10.1186/alzrt150 · Cited by 90
Solvents and Parkinson disease: A systematic review of toxicological and epidemiological evidence
Lock, E. A., Zhang, J., & Checkoway, H. (2012) · Toxicology and Applied Pharmacology · doi:10.1016/j.taap.2012.11.016 · Cited by 89
Research works printed but not linked: 15
- Bergen, 1971, The in vitro effect of dieldrin on respiration of rat liver mitochondria, Proc. Soc. Exp. Biol. Med., 136, 732, 10.3181/00379727-136-35352 · doi:10.3181/00379727-136-35352
- Couper, 1837, On the effects of black oxide of manganese when inhaled into the lungs, Br. Ann. Med. Pharmacol., 1, 41
- Harischandra, 2015, α-Synuclein protects against manganese neurotoxic insult during the early stages of exposure in a dopaminergic cell model of Parkinson’s disease, Toxicol. Sci., 143, 454, 10.1093/toxsci/kfu247 · doi:10.1093/toxsci/kfu247
- Kala, 1995, Low level lead exposure decreases in vivo release of dopamine in the rat nucleus accumbens: a microdialysis study, J. Neurochem., 65, 1631, 10.1046/j.1471-4159.1995.65041631.x · doi:10.1046/j.1471-4159.1995.65041631.x
- Kochen, 2003, The endogeneous formation of highly chlorinated tetrahydro-beta-carbolines as a possible causative mechanism in idiopathic Parkinson’s disease, Adv. Exp. Med. Biol., 527, 253, 10.1007/978-1-4615-0135-0_29 · doi:10.1007/978-1-4615-0135-0_29
- Li, 2014a, The effects of early life Pb exposure on the expression of IL1-beta, TNF-alpha and Abeta in cerebral cortex of mouse pups, J. Trace Elem. Med. Biol., 28, 100, 10.1016/j.jtemb.2013.07.003 · doi:10.1016/j.jtemb.2013.07.003
- Liu, 2014, Effects of lead exposure on the expression of amyloid beta and phosphorylated tau proteins in the C57BL/6 mouse hippocampus at different life stages, J. Trace Elem. Med. Biol., 28, 227, 10.1016/j.jtemb.2014.01.002 · DOI
- Lu, 1994, Levodopa failure in chronic manganism, Neurology, 44, 1600, 10.1212/wnl.44.9.1600 · doi:10.1212/wnl.44.9.1600
- Papageorgiou, 2009, Severe dopaminergic pathways damage in a case of chronic toluene abuse, Clin. Neurol. Neurosurg., 111, 864, 10.1016/j.clineuro.2009.07.007 · doi:10.1016/j.clineuro.2009.07.007
- Pezzoli, 1989, Parkinsonism due to n-hexane exposure, Lancet, 2, 874, 10.1016/s0140-6736(89)93050-x · doi:10.1016/s0140-6736(89)93050-x
- Pezzoli, 1990, n-hexane induces parkinsonism in rodents, Brain Res., 531, 355, 10.1016/0006-8993(90)90801-h · doi:10.1016/0006-8993(90)90801-h
- Purkerson-Parker, 2001, Dopamine transporter binding in the rat striatum is increased by gestational, perinatal and adolescent exposure to heptachlor, Toxicol. Sci., 64, 216, 10.1093/toxsci/64.2.216 · doi:10.1093/toxsci/64.2.216
- Singer, 1997, Tau in aluminum-induced neurofibrillary tangles, Neurotoxicology, 18, 63
- Tokimasa, 2005, Importance of local structures of second and third repeat fragments of microtubule-binding domain for tau filament formation, FEBS Lett., 579, 3481, 10.1016/j.febslet.2005.05.020 · doi:10.1016/j.febslet.2005.05.020
- Wagner, 1978, Dieldrin-induced alterations in biogenic amine content of rat brain, Toxicol. Appl. Pharmacol., 43, 45, 10.1016/s0041-008x(78)80031-3 · doi:10.1016/s0041-008x(78)80031-3
Cited by
Oxidative Stress: A Key Modulator in Neurodegenerative Diseases
Singh, A., Kukreti, R., Saso, L., & Kukreti, S. (2019) · Molecules · doi:10.3390/molecules24081583 · Cited by 2,254
The effects of heavy metals on human metabolism
Fu, Z., & Xi, S. (2020) · Toxicology Mechanisms and Methods · doi:10.1080/15376516.2019.1701594 · Cited by 1,025
The role of interleukin-6 signaling in nervous tissue
Rothaug, M., Becker-Pauly, C., & Rose-John, S. (2016) · Biochimica et Biophysica Acta (BBA) - Molecular Cell Research · doi:10.1016/j.bbamcr.2016.03.018 · Cited by 491
The toxicology of mercury: Current research and emerging trends
Bjørklund, G., Dadar, M., Mutter, J., & Aaseth, J. (2017) · Environmental Research · doi:10.1016/j.envres.2017.08.051 · Cited by 482
Comunian, S., Dongo, D., Milani, C., & Palestini, P. (2020) · International Journal of Environmental Research and Public Health · doi:10.3390/ijerph17124487 · Cited by 464
Metadata
- Authors
- Chin-Chan, M., Navarro-Yepes, J., & Quintanilla-Vega, B.
- Venue
- Frontiers in Cellular Neuroscience
- Publisher
- Frontiers Media SA
- Published
- 2015-04-10
- Volume
- 9
- Pages
- 124-124
- ISSN
- 1662-5102 (ISSN-L)
- OpenAlex
- W2034578928
- Cited by
- 707
- References
- 254
- FWCI
- 37.02
- Type
- journal article
- Language
- en
- Open access
- gold
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.